Glycomics: Sugar Coating is More than Decoration

By the mid 1990s, most of the early carbohydrate drug development companies were either defunct or had repositioned themselves. But academia continued to advance gycobiology analysis tools. Today, thanks to improved mass spec and bioinformatic methods, as well as newly-revealed structure-activity relationships, a new generation of glycomics companies has a chance to succeed where forebears failed.

More from Archive

More from Scrip